Appendix A: Appraisal Committee members, guideline representatives and NICE project team
A Appraisal Committee members
The Appraisal Committees are standing advisory committees of NICE. Members are appointed for a 3-year term. A list of the Committee members who took part in the discussions for this appraisal appears below. There are four Appraisal Committees, each with a chair and vice chair. Each Appraisal Committee meets once a month, except in December when there are no meetings. Each Committee considers its own list of technologies, and ongoing topics are not moved between Committees.
Committee members are asked to declare any interests in the technology to be appraised. If it is considered there is a conflict of interest, the member is excluded from participating further in that appraisal.
The minutes of each Appraisal Committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.
Professor Darren Ashcroft
Professor of Pharmacoepidemiology, School of Pharmacy and Pharmaceutical Sciences, University of Manchester
Dr Matthew Bradley
Value Demonstration Director, AstraZeneca
Dr Brian Buckley
Lay Member
Professor Usha Chakravarthy
Professor of Ophthalmology and Vision Sciences, The Queen's University of Belfast
Professor Peter Clark (Chair)
Consultant Medical Oncologist, Clatterbridge Centre for Oncology
Dr Ian Davidson
Lecturer in Rehabilitation, The University of Manchester
Professor Simon Dixon
Senior Lecturer in Health Economics, University of Sheffield
Dr Martin Duerden
Medical Director, Conwy Local Health Board
Dr Alexander Dyker
Consultant Physician, Wolfson Unit of Clinical Pharmacology
Dr Jon Fear
Consultant in Public Health Medicine, Head of Healthcare Effectiveness NHS Leeds
Paula Ghaneh
Senior Lecturer and Honorary Consultant, University of Liverpool
Niru Goenka
Consultant Physician, Countess of Chester NHS Foundation Trust
Susan Griffin
Research Fellow, University of York
Professor Carol Haigh
Professor in Nursing, Manchester Metropolitan University
Alison Hawdale
Lay Member
Professor John Hutton
Professor of Health Economics, University of York
Professor Peter Jones
Emeritus Professor of Statistics, Keele University
Dr Steven Julious
Senior Lecturer in Medical Statistics, University of Sheffield
Dr Vincent Kirkbride
Consultant Neonatologist, Regional Neonatal Intensive Care Unit, Sheffield
Dr Rachel Lewis
Doctoral Researcher
Dr Anne McCune
Consultant Hepatologist, University Hospitals Bristol NHS Foundation Trust
Professor Jonathan Michaels (Vice Chair)
Professor of Vascular Surgery, University of Sheffield
Professor Femi Oyebode
Professor of Psychiatry & Consultant Psychiatrist, The National Centre for Mental Health
Dr John Radford
Director of Public Health, Rotherham Primary Care Trust
Dr Phillip Rutledge
GP and Consultant in Medicines Management, NHS Lothian
Dr Brian Shine
Consultant Chemical Pathologist, John Radcliffe Hospital
Dr Murray D Smith
Associate Professor in Social Research in Medicines and Health, University of Nottingham
Paddy
Storrie
Lay Member
Dr Cathryn Thomas
GP and Associate Professor, The University of Birmingham
Dr Lok Yap
Consultant in Acute Medicine & Clinical Pharmacology, Whittington Hospitals NHS Trust
B Guideline representatives
The following individual, representing the Guideline Development Group responsible for developing NICE's clinical guideline related to this topic, was invited to attend the meeting to observe and to contribute as an adviser to the Committee.
-
Dr Chris Deighton, Rheumatoid Arthritis Management Guideline Development Group